Skip to content

Study to assess the relative bioavailability of Neludolat versus YAZ in healthy female subjects.

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524871-22-00
Enrollment
24
Registered
2026-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

None listed

Sponsors

Pevisal Group Farmaceutici S.r.l.
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 13, 2026